The House Ways and Means Oversight Subcommittee today held a hearing focused on the Centers for Medicare & Medicaid Services’ efforts to use data to identify Medicare Part D beneficiaries who are at risk of misusing opioids. The hearing also examined the tools CMS has available to limit overprescribing. Witnesses were Kimberly Brandt, CMS principal deputy administrator for operations; Gary Cantrell, deputy inspector general for investigations at the Department of Health and Human Services’ Office of Inspector General; and Elizabeth Curda, director of health care at the Government Accountability Office. In addition, the Senate Committee on Homeland Security and Governmental Affairs today examined Medicaid and the opioid epidemic. Witnesses were Sam Adolphsen, senior fellow at the Foundation for Government Accountability; Otto Schalk, prosecuting attorney for Harrison County, IN; Emmanuel Tyndall, inspector general of Tennessee; David Hyman, M.D., of the Georgetown University Law Center; and Andrew Kolodny, M.D., co-director of opioid policy research at Brandeis University.

Related News Articles

Headline
The Substance Abuse and Mental Health Services Administration will launch a three-part virtual learning series on recovery supports for people considering or…
Headline
Drug overdose deaths declined 5.1% in 2018 to about 68,000, according to preliminary data from the Centers for Disease Control and Prevention.
Headline
Under a new Centers for Medicare…
Headline
Six health care organizations in rural North Carolina communities will share $1.2 million in federal grant funds to strengthen and expand their response to…
Headline
The Food and Drug Administration yesterday released new draft guidance for labeling medications that carry the risk of abuse or dependence, including but not…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic will host a free public webinar July 22 at 3 p.m. ET on best…